Figure 3.
Main findings regarding the alterations of ECS components in animal models and patients with depression. 2-AG: 2-arachidonoylglycerol; ACC: anterior cingulate cortex; AEA: anandamide; CB1r: cannabinoid receptor 1; CNR1: gene encoding CB1r; FAAH: gene encoding fatty acid amide hydrolase; FSL: Flinders Sensitive Line rats; HIPP: hippocampus; HYP: hypothalamus; MDD: major depressive disorder; MGLL: gene encoding MAGL; NAcc: nucleus accumbens; PFC: prefrontal cortex; SSRI: selective serotonin reuptake inhibitors; ST: striatum; WKY: Wistar Kyoto rats.